Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (540)	1/18/2000 6:28:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 579

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Since November 11, 1999, Partners, in its capacity as general partner of BVF and on behalf of such limited partnership, has sold to SIBIA in connection with a merger between SIBIA and Merck & Co., Inc. 755,250 shares of the Stock for consideration of $6,419,925. In addition, Partners, in its capacity as investment manager with respect to certain managed accounts, and on behalf of such managed accounts, has sold to SIBIA in connection with a merger between SIBIA and Merck & Co., Inc. an aggregate number of 675,750 shares of the Stock for an aggregate consideration of $5,743,875. Item 4 is hereby amended to read in its entirety as follows: ITEM 4. PURPOSE OF TRANSACTIONS. The sole purpose of the original acquisition of the Stock and its disposition, as reported herein, was for investment. At no time have the Reporting Persons had any plan to acquire control of SIBIA. The Reporting Persons have no intent to engage in any further transactions in the Stock. Item 5 is hereby amended to read in its entirety as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) As of January 11, 2000, none of the Reporting Persons beneficially own any shares of the Stock. (b) As of January 11, 2000, none of the Reporting Persons nor any managed account beneficially own any shares of the Stock. The managed accounts on whose behalf Partners previously owned shares of the Stock were Investment 10 L.L.C., an Illinois limited liability company ("ILL10") and Biotechnology Value Fund, Ltd., a Cayman Islands Corporation ("BVF Ltd.").